Yesterday we announced a strategic reorganization to prioritize investments in our platform technologies with an extended cash runway. As a result, we made the extremely difficult decision to reduce the size of our team. Every single one of those impacted have contributed significantly to our scientific advances over the past 6 years, showing incredible dedication to the Generation Bio community and our mission. We are focused supporting these talented, thoughtful individuals to find new opportunities as exceptional as they are and are putting together a resume book. If you'd like a copy please share your email below.
Generation Bio
Biotechnology Research
Cambridge, Massachusetts 12,210 followers
We’re pushing the limits of genetic medicine. And our goal is no limits.
About us
Generation Bio is innovating genetic medicines to provide durable, redosable treatments for people living with rare and prevalent diseases. The company’s non-viral genetic medicine platform incorporates a novel immune-quiet DNA called iqDNA; a unique cell-targeted lipid nanoparticle delivery system, or ctLNP; and a highly scalable capsid-free manufacturing process that uses proprietary cell-free rapid enzymatic synthesis, or RES, to produce iqDNA. This approach is designed to enable multi-year durability from a single dose, to deliver large genetic payloads, including multiple genes, to specific tissues and cell types, and to allow titration and redosing to adjust or extend expression levels in each patient. RES has the potential to expand Generation Bio’s manufacturing scale to hundreds of millions of doses to support its mission to extend the reach of genetic medicine to more people, living with more diseases, around the world.
- Website
-
http://www.generationbio.com
External link for Generation Bio
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Cambridge, Massachusetts
- Type
- Public Company
- Founded
- 2016
- Specialties
- Biotechnology, Rare Disease, Gene Therapy, LNPs, DNA, and Non-Viral Gene Therapy
Locations
-
Primary
Get directions
301 Binney Street
4th Floor
Cambridge, Massachusetts 02142, US
Employees at Generation Bio
Updates
-
We are pleased to announce the latest progress in our mission to unlock the full potential of genetic medicine through the latest advancements with our cell-targeted LNP (ctLNP) platform. Learn more in our press release here: https://lnkd.in/eiwzBrAz
-
Today, Generation Bio announced an exciting step forward in our mission to realize the full potential of non-viral DNA therapeutics with the development of a proprietary, novel DNA called immune-quiet DNA (iqDNA). Read our press release here to learn more: https://lnkd.in/eN8axuDw
-
-
Last week, our Chief Scientific Officer, Matthew Stanton, discussed the key hurdles for non-viral DNA delivery and innate immune stimulation, as well as strategies to address these challenges in an online webinar with the Oligonucleotide Therapeutics Society. Check it out here to learn more: https://bit.ly/45yQjxs
-
-
Today, our CEO, Geoffrey McDonough, M.D., will participate in a fireside chat at the Jefferies Cell & Genetic Medicine Summit. Learn more: https://bit.ly/456AEoE
-
-
Tune in today catch our very own project management experts, Paul B Cook, PhD, PMP, Joyce Pinkham and Mariamawit Gebremeskel as they discuss the diversity of project management approaches and share their experiences as PMs in a dynamic biotech environment with PIPMG.
Helping organizations cooperate and collaborate to leverage complimentary strengths needed for synergistic pioneering. Seek the right-sized processes needed to effectively and efficiently target, plan and execute.
Looking forward to working with my colleagues, Joyce Pinkham and Mari Gebremeskel, to share the diversity of PM applications in our small-ish biotech company.
Diversity of Project Management Approaches in a Small Biotechnology Company - PIPMG - Pharmaceutical Industry Project Management Group
https://pipmg.org
-
Today, our CFO, Matthew Norkunas, M.D., will present at the Canaccord Genuity 43rd Annual Growth Conference in Boston. Learn more here: https://bit.ly/3YtWzo1
-